Who is sponsoring NCT04104711?

NCT04104711 is sponsored by Dilay AÇIL,PhD.

What drugs are being tested in NCT04104711?

Interventions in NCT04104711: Home visits, health education.

What condition does NCT04104711 study?

NCT04104711 studies Diabetes Mellitus, Type 2, Home Visit.

Is NCT04104711 still recruiting?

NCT04104711 is currently completed. Last updated 30 September 2019.

Last reviewed 2019-09-30 · How we verify

NCT04104711

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home-Based Intervention to the Diabetics

Completed NA Last updated 30 September 2019

What this trial tests

NA trial testing Home visits, health education in Diabetes Mellitus, Type 2 in 81 participants. Completed in 14 July 2017.

Timeline

1 January 2015

Primary endpoint
30 March 2017

14 July 2017

Quick facts

Lead sponsor	Dilay AÇIL,PhD
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	81
Start date	1 January 2015
Primary completion	30 March 2017
Estimated completion	14 July 2017

Drugs / interventions tested

Home visits, health education

Conditions studied

Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Home Visit — all drugs for Home Visit →

Sponsor

Dilay AÇIL,PhD

Who can join

18 and older, any sex, with Diabetes Mellitus, Type 2 or Home Visit. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Why is the research needed? * This study reflects the complexity of the process that patients with diabetes are experiencing when staying at home away from the supervision of health professionals. In this context, there is a gap in the literature on home care of diabetes. * The barriers, facilitators and the other perceptions that affect each diabetic's compliance with the disease-related recommendation are different. Nurses need to be aware of this. * For this reason, according to the Health Belief Model, an original study was conducted to evaluate the nursing intervention program's results on patient care and cost-effectiveness in a home for supporting self-management of diabetic patients. Hypotheses of the Study Patients with diabetes undergoing home-based nursing interventions in line with the Health Belief Model. H1: have higher mean scores for the Health Belief Model Scale than the control group. H2: have higher mean scores for the Self-Efficacy Scale than the control group. H3: have lower HbA1c levels than the control group. H4: have lower blood glucose levels (BGL) than the control group. H5: have lower blood pressure levels than the control group. H6: have lower BMI levels than the control group. H7: have fewer hospital admissions due to an acute or chronic complication than the control group. H8: have a lower complication-related cost rate than the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus, Type 2

Currently open trials in the same condition.

NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04104711 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dilay AÇIL,PhD
Last refreshed: 30 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04104711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing